CIK: 1379344 - Address: C/O Adverum Biotechnologies, Inc., 100 Cardinal Way, Redwood City, CA 94063
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
3/17/23 18:01
3/15/23
ADVMAdverum Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagFischer LaurentCADOCEO,P,DiS-320.78160-41-6692D
9/21/22 19:57
9/19/22
ADVMAdverum Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagFischer LaurentCADOCEO,P,DiS-441.070-41-5727D
4/22/22 17:00
4/20/22
ADVMAdverum Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagFischer LaurentCADOCEO,P,DiP281.110253762D
12/10/21 17:26
12/8/21
ADVMAdverum Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagFischer LaurentCADOCEO,P,DiP.m461.820254737D
3/24/21 19:47
3/24/21
ADVMAdverum Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagFischer LaurentCADOCEO,DirP999.880106126D
1/19/21 20:32
1/15/21
ADVMAdverum Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagFischer LaurentCADOCEO,DirP9911.530911216D
8/19/20 18:45
8/17/20
ADVMAdverum Biotechnologies, Inc.DEHealthBioPrdBiological Products, (No DiagFischer LaurentCADOCEO,DirP10013.0008New8D
9/18/19 17:23
9/16/19
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFischer LaurentCADP.m209.3902457D
9/10/19 19:10
9/6/19
MIRMMirum Pharmaceuticals, Inc.DEHealthDrugPharmaceutical PreparationsFischer LaurentCADP.m4910.6005New5D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact